Vanguard National Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.97M Sell
4,977
-9
-0.2% -$9.2K 0.33% 39
2026
Q1
$4.59M Buy
+4,986
New +$5.05M 0.29% 45

Other funds holding LLY

Vanguard National Trust's LLY Position: Q2 2026 in Review

Vanguard National Trust reduced its Eli Lilly (LLY) stake by 0.18% in Q2 2026, selling an estimated $9.2K and leaving 4,977 shares worth $5.97M. The position accounts for 0.33% of the portfolio, ranked #39.

Vanguard National Trust first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,564 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vanguard National Trust held 4,977 shares of Eli Lilly worth $5.97M as of Q2 2026.
  • Vanguard National Trust sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.33% of Vanguard National Trust's portfolio in Q2 2026, its #39 holding.
  • Vanguard National Trust first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.